Around 33% of the participants on the higher dose also experienced very high levels of weight loss losing 25% or more of their total body weight
Rupniak HT, Rowlatt C, Lane EB, Steele JG, Trejdosiewicz LK, Laskiewicz B, Povey S, Hill BT
Management: This is generally a good sign that it's working
This multi-disciplinary synergy reduces the fragmentation of care often experienced when dealing with multiple specialists, making your health journey more cohesive and convenient
[1] Novo Nordisk got it approved for type 2 diabetes back in 2017 as Ozempic, then for weight management in 2021 as Wegovy, dosed at 2.4 mg by injection once a week
Craddy, P., Palin, H